General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Pharvaris ×

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition.

  • Sector: Life Sciences
  • Headquarters: Zug, Switzerland
  • Date Invested: 11/5/2020
  • Visit Website

Chi-Med ×

Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.

  • Sector: Life Sciences
  • Headquarters: Hong Kong, China
  • Date Invested: 07/2/2020
  • Visit Website

CANbridge ×

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.

  • Sector: Life Sciences
  • Headquarters: Beijing, China
  • Date Invested: 03/10/2020
  • Visit Website

Royalty Pharma ×

Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.

  • Sector: Life Sciences
  • Headquarters: New York, NY
  • Date Invested: 02/4/2020
  • Visit Website

Adagene ×

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.

  • Sector: Life Sciences
  • Headquarters: Suzhou, China
  • Date Invested: 12/19/2019
  • Visit Website

Allonnia ×

Allonnia leverages advanced technologies and biology to engineer breakthrough systems to develop and commercialize new waste remediation and management solutions.

  • Sector: Life Sciences
  • Headquarters: Boston, United States
  • Date Invested: 12/18/2019
  • Visit Website

Immunocore ×

Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and autoimmune disorders.

  • Sector: Life Sciences
  • Headquarters: Oxfordshire, United Kingdom
  • Date Invested: 08/13/2019
  • Visit Website

OcuMension ×

Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.

  • Sector: Life Sciences
  • Headquarters: Shanghai, China
  • Date Invested: 06/18/2019

Motif FoodWorks ×

Motif FoodWorks is a synthetic biology company that designs and sells ingredients to companies that make plant-based foods and beverages.

  • Sector: Life Sciences
  • Headquarters: Boston, MA
  • Date Invested: 04/26/2019
  • Visit Website

PathAI ×

PathAI is a leading provider of AI-powered research tools and services for pathology.

  • Sector: Life Sciences
  • Headquarters: Boston, MA
  • Date Invested: 04/10/2019
  • Visit Website

Rubicon Research ×

Rubicon is a specialty generics pharmaceutical product-development company engaged in research, development and manufacturing of branded and specialty generic products and OTC products.

  • Sector: Life Sciences
  • Headquarters: Mumbai, Maharashtra, India
  • Date Invested: 04/4/2019
  • Visit Website

Ginkgo Bioworks ×

Ginkgo Bioworks is a synthetic biology company that designs and licenses DNA code for custom designed organisms.

  • Sector: Life Sciences
  • Headquarters: Boston, MA
  • Date Invested: 12/13/2017
  • Visit Website

Sanfer ×

Sanfer is one of the largest independent pharmaceutical companies in Mexico, operating in nine countries across Latin America.

  • Sector: Life Sciences
  • Headquarters: Mexico City, Mexico
  • Date Invested: 05/20/2014
  • Visit Website